Sanofi (FRA:SNW)
87.79
+1.34 (1.55%)
Last updated: Oct 24, 2025, 1:30 PM CET
Sanofi Revenue
Sanofi had revenue of 13.17B EUR in the quarter ending September 30, 2025, a decrease of -6.97%. This brings the company's revenue in the last twelve months to 45.93B, down -5.19% year-over-year. In the year 2024, Sanofi had annual revenue of 44.29B with 7.73% growth.
Revenue (ttm)
45.93B
Revenue Growth
-5.19%
P/S Ratio
2.30
Revenue / Employee
551.87K
Employees
82,878
Market Cap
105.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.29B | 3.18B | 7.73% |
| Dec 31, 2023 | 41.11B | 805.00M | 2.00% |
| Dec 31, 2022 | 40.30B | 1.13B | 2.88% |
| Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
| Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 139.36B |
| Deutsche Telekom AG | 120.55B |
| Allianz SE | 109.02B |
| Siemens Aktiengesellschaft | 78.30B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
| Siemens Energy AG | 38.39B |
| SAP SE | 36.49B |
| Deutsche Bank Aktiengesellschaft | 30.07B |
Sanofi News
- 4 hours ago - Sanofi (SNY) Boosts Q3 Profits Through Strategic Pharma Launches - GuruFocus
- 5 hours ago - Sanofi Earnings Driven by New Medicine Sales, Dupixent Performance - WSJ
- 5 hours ago - Sanofi Q3 Profit Edges Down, Net Sales Rise; Confirms FY25 View, Sees Profitable Growth In FY26 - Nasdaq
- 6 hours ago - Sanofi reports Q3 results - Seeking Alpha
- 6 hours ago - Sanofi's quarterly profit boosted by Dupixent and newer drugs, forecast unchanged - Reuters
- 1 day ago - Sanofi Deepens Partnership with Medidata to Expedite the Development of New Therapies with an Improved Patient Journey - GlobeNewsWire
- 1 day ago - Sanofi Drug Shows Superior Efficacy In Genetic Disease Compared To Current Standard Therapy - Benzinga
- 2 days ago - Sanofi's Efdoralprin Alfa Meets All Endpoints In Phase 2 AATD Emphysema Study - Nasdaq